Company intelligence / Profile preview
Biovac
Cape Town, Western Cape, South Africabiovac.co.za ↗
- Ownership
- Private
- Employees
- ~475
- Development stage
- Commercial
01
Overview
Biovac supplies over fifteen million doses annually across South Africa and neighboring countries. It has successfully transferred technology from global partners like Sanofi and Pfizer to locally manufacture paediatric combination vaccines and the Pfizer-BioNTech COVID‑19 mRNA vaccine. Its pentavalent combination vaccine project was discontinued due to regulatory changes but it continues to expand its portfolio with new partnerships.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccinemRNA-based drugsRecombinant proteinConjugate vaccine
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Pfizer/BioNTech — local manufacture of the Pfizer-BioNTech COVID‑19 Vaccine for Africa.Sanofi Pasteur — technology transfer for hexavalent pediatric combination vaccines.World Health Organization/COVAX — participation in the first African mRNA tech transfer hub.Wellcome Trust — collaboration on scaling up African manufacturing capacity.Boston Consulting Group — strategic consulting support.
Beyond the preview
Go deeper on Biovac.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biovac.